HIGHLIGHTS
SUMMARY
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes the coronavirus disease 2019 (COVID-19), has high morbidity and mortality rates. Remdesivir`s effectiveness against SARS-CoV-2 and related coronaviruses was supported by in_vitro and preclinical in_vivo animal models. Is a current in_vitro investigation of remdesivir`s antiviral activity against SARS-CoV-2 (formerly known as 2019-nCov, strain nCoV-2019BetaCoV/Wuhan/WIV04/2019) that measured the viral copy number in infected Vero E6 cells using qRT-PCR. Remdesivir`s effectiveness in_vivo in inhibiting viral_replication and reducing viral-associated pathologies against . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.